Shareholders' Equity and Equity Incentive Plans (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Equity [Abstract] |
|
| Summary of Stock Option Activity |
A summary of share option activity under the Company’s equity incentive plans and related information is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
|
|
Outstanding
Share Options |
|
|
Weighted-Average Exercise
Price |
|
|
Weighted-Average Remaining
Contractual
Life (Years) |
|
|
Aggregate
Intrinsic
Value |
|
|
|
(in thousands, except share, life and per share data) |
|
Outstanding as of December 31, 2025 |
|
|
1,428,546 |
|
|
$ |
10.59 |
|
|
|
3.3 |
|
|
$ |
74,162 |
|
Exercised |
|
|
(510,075 |
) |
|
$ |
9.41 |
|
|
|
|
|
$ |
30,664 |
|
Outstanding and exercisable as of June 30, 2026 |
|
|
918,471 |
|
|
$ |
11.26 |
|
|
|
3.0 |
|
|
$ |
73,133 |
|
|
| Summary of Restricted Ordinary Shares |
A summary of restricted share units (“RSU”) activity under the Company’s equity incentive plan and related information is as follows:
|
|
|
|
|
|
|
|
|
|
|
RSUs |
|
|
|
Unvested RSUs |
|
|
Weighted-Average
Grant Date Fair
Value Per Share |
|
Unvested as of December 31, 2025 |
|
|
9,838,786 |
|
|
$ |
34.76 |
|
Granted |
|
|
1,377,466 |
|
|
$ |
57.61 |
|
Vested |
|
|
(2,728,703 |
) |
|
$ |
32.74 |
|
Forfeited |
|
|
(476,077 |
) |
|
$ |
36.74 |
|
Unvested as of June 30, 2026 |
|
|
8,011,472 |
|
|
$ |
39.25 |
|
|
| Summary of Ordinary Shares Reserved for Future Issuance |
The Company has the following ordinary shares reserved for future issuance:
|
|
|
|
|
|
|
June 30, 2026 |
|
Outstanding share options |
|
|
918,471 |
|
Outstanding RSUs |
|
|
8,011,472 |
|
Issuable ordinary shares related to business combination |
|
|
502,906 |
|
Shares available for future issuance under the 2020 Plan |
|
|
24,166,184 |
|
Shares available for future issuance under ESPP |
|
|
6,605,218 |
|
Total ordinary shares reserved |
|
|
40,204,251 |
|
|
| Summary of Stock-Based Compensation Expense |
The share-based compensation expense by line item in the accompanying Condensed Consolidated Statements of Operations is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
|
|
(in thousands) |
|
Cost of revenue: subscription–self-managed and SaaS |
|
$ |
4,076 |
|
|
$ |
4,209 |
|
|
$ |
8,169 |
|
|
$ |
8,410 |
|
Research and development |
|
|
13,981 |
|
|
|
14,186 |
|
|
|
28,191 |
|
|
|
28,163 |
|
Sales and marketing |
|
|
12,518 |
|
|
|
13,357 |
|
|
|
25,327 |
|
|
|
26,087 |
|
General and administrative |
|
|
9,002 |
|
|
|
6,257 |
|
|
|
17,517 |
|
|
|
12,194 |
|
Total share-based compensation expense |
|
$ |
39,577 |
|
|
$ |
38,009 |
|
|
$ |
79,204 |
|
|
$ |
74,854 |
|
|